Precision AI for
Complex Diagnostics.
NoryaAI bridges the gap between raw data and clinical intuition. Our methodology transforms biochemical signals into actionable health intelligence.
"We focus on turning raw lab values into a clearer, more structured report people can review with their clinician."
NoryaAI methodology team
Clinical review principles
The Neural Network of
Human Physiology
Our proprietary AI models analyze over 150 distinct biomarkers simultaneously, accounting for age-adjusted baselines, seasonal variability, and genetic predispositions. This multi-layered synthesis identifies patterns invisible to the human eye.
Privacy-first handling
Encrypted transport, controlled report access, and platform policies designed for responsible health-data handling.
98.7% Classification Accuracy
Internal platform evaluation of biomarker classification against reference ranges. See methodology for scope and limits.
Clinical Review Principles
NoryaAI is built around reviewable interpretation rules, structured outputs, and transparent limits rather than opaque medical claims.
Reference-range logic
Interpretation layer
Compares biomarkers against structured reference ranges and report context.
Quality controls
Platform safeguards
Flags missing, inconsistent, or hard-to-parse values before final report generation.
Structured output
Patient readability
Turns complex lab data into readable summaries, grouped markers, and follow-up prompts.
Transparent limits
Safety framing
Educational support only, with explicit guidance to review abnormal findings with clinicians.
Methodology
Foundations
Our product logic is informed by standard laboratory reference ranges, clinical interpretation patterns, and internal quality evaluation. We aim to explain clearly what our metrics mean and what they do not mean.
View Full Publications arrow_right_altHow biomarker classification works on NoryaAI
What our accuracy metric includes and excludes
How safety and educational framing are applied
Platform Reference Coverage
NoryaAI is designed to work across common blood test formats, multilingual report outputs, and structured biomarker interpretation flows. We focus on explainability and consistency rather than inflated database claims.
200+
Biomarkers handled
9+
Report languages
50+
Countries reached
Real lab exports supported